(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(7-methyl-1H-indol-3-yl)propanoic acid, 98+%, 10g

Ethyl 2-bromo-5-methyl-4H-imidazole-4-carboxylate, 95.0%, 25g

Ethyl3-bromo-6,6-difluoro-5,7-dihydropyrazolo[5,1-b][1,3]oxazine-2-carboxylate, 98%, 250mg

Methyl 4-bromo-1-methyl-1H-imidazole-2-carboxylate, 95.0%, 10g

(6-Chloro-2-methanesulfonyl-pyrimidin-4-yl)-methyl-amine, 98.0%, 250mg

4,4'-Thiobisbenzenethiol, 98.0%, 10g

6-BROMOBENZO[B]THIOPHENE-3-CARBALDEHYDE, 95.0%, 100mg

1-(3-Chloro-4-fluorobenzoyl)piperidin-4-one, 97%, 1g

(4-Chloro-3-(trifluoromethoxy)phenyl)boronic acid, 97%, 250mg

Plan stress-free PLPOLi 10x/0.25 IOS objective for iScope incident polarization, no cover glass correction. Working distance 10 mm

(R)-4-(TERT-BUTOXY)-2-ISOPROPYL-4-OXOBUTANOIC ACID, 95.0%, 1g

4-N-Boc-Amino-4-carboxytetrahydropyran, 95.0%, 5g

2-Chloro-1-(1-methyl-1h-pyrazol-4-yl)ethan-1-one, 95%, 100mg